{"title":"Hospice news","authors":"","doi":"10.1177/104990910302000403","DOIUrl":null,"url":null,"abstract":"As more and more healthcare products that patients at one time could only get through hospitals for use under a doctor’s supervision become available for home use, manufacturers, insurers, and physicians face an increased risk of potential litigation. Patients are now able to self-administer once complicated treatments and operate medical devices, such as dialysis machines or blood testing kits. However, along with the convenience and reduced healthcare costs associated with these products comes the likelihood that some patients will use them incorrectly. If injuries occur, lawsuits are likely not far behind. “It’s a fairly challenging type of risk to underwrite for us,” said Jill Wadlund, vice-president and casualty manager with Chubb & Son, Whitehouse Station, New Jersey. According to Ms. Wadlund, at-home healthcare products have been in use for decades, but the segment has grown substantially over the last three or four years. “It’s not going to go away. If anything, it’s going to get bigger.” Ms. Wadlund said manufacturers need to keep a number of factors in mind when designing products for use in patients’ homes. Chubb works with clients through the testing and clinical trials, FDA approval process, and product introduction phases. “We like to start with them at the very beginning when they’re in the R & D phase,” Ms. Wadlund said. “They need to demonstrate to us when they design the product that they understand the environment in which it’s being used. In a hospital setting, they can be a little more attentive.” Pete DeComo, CEO of Renal Solutions Inc., a manufacturer of kidney dialysis products, said insurance can be a tricky issue for companies that make medical products for home use. Since premiums are usually based on revenue generated, the more units that are sold, the greater the potential liability exposure will be. “I think any company coming into a market like this needs to realize your premiums are going to be high,” Mr. DeComo said. “It is one of the challenges any time you’re using a device that’s considered to be high risk.” Tom Sweeney, a product liability attorney with Eckert Seamans Cherin & Mellott in Pittsburgh who works with manufacturers such as General Motors, warns that litigation can still result when something goes wrong, no matter how much care a manufacturer puts into development or the warning labels that accompany it. “When you have a product like that, in the hands of the consumer . . . you are exposed to being sued, even if it’s that person’s fault,” Mr. Sweeney said. Companies looking to reduce their exposure to litigation should look for ways to build good relationships with their consumers before potential problems arise. “That goodwill tends to reduce, more than anything, litigation,” Mr. Sweeney said. Mr. DeComo realizes having to defend against litigation is a possibility for many companies that make medical products for at-home use. “It’s one of those situations where we’re stuck between a rock and a hard place,” he said. “You’re trying to help patients, and you’re trying to make products as safe as possible, but anyone can come after a company.” (Source: Pittsburgh Business Times, April 14, 2003.)","PeriodicalId":7716,"journal":{"name":"American Journal of Hospice and Palliative Medicine®","volume":"7 1","pages":"255 - 257"},"PeriodicalIF":0.0000,"publicationDate":"2003-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Hospice and Palliative Medicine®","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/104990910302000403","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

As more and more healthcare products that patients at one time could only get through hospitals for use under a doctor’s supervision become available for home use, manufacturers, insurers, and physicians face an increased risk of potential litigation. Patients are now able to self-administer once complicated treatments and operate medical devices, such as dialysis machines or blood testing kits. However, along with the convenience and reduced healthcare costs associated with these products comes the likelihood that some patients will use them incorrectly. If injuries occur, lawsuits are likely not far behind. “It’s a fairly challenging type of risk to underwrite for us,” said Jill Wadlund, vice-president and casualty manager with Chubb & Son, Whitehouse Station, New Jersey. According to Ms. Wadlund, at-home healthcare products have been in use for decades, but the segment has grown substantially over the last three or four years. “It’s not going to go away. If anything, it’s going to get bigger.” Ms. Wadlund said manufacturers need to keep a number of factors in mind when designing products for use in patients’ homes. Chubb works with clients through the testing and clinical trials, FDA approval process, and product introduction phases. “We like to start with them at the very beginning when they’re in the R & D phase,” Ms. Wadlund said. “They need to demonstrate to us when they design the product that they understand the environment in which it’s being used. In a hospital setting, they can be a little more attentive.” Pete DeComo, CEO of Renal Solutions Inc., a manufacturer of kidney dialysis products, said insurance can be a tricky issue for companies that make medical products for home use. Since premiums are usually based on revenue generated, the more units that are sold, the greater the potential liability exposure will be. “I think any company coming into a market like this needs to realize your premiums are going to be high,” Mr. DeComo said. “It is one of the challenges any time you’re using a device that’s considered to be high risk.” Tom Sweeney, a product liability attorney with Eckert Seamans Cherin & Mellott in Pittsburgh who works with manufacturers such as General Motors, warns that litigation can still result when something goes wrong, no matter how much care a manufacturer puts into development or the warning labels that accompany it. “When you have a product like that, in the hands of the consumer . . . you are exposed to being sued, even if it’s that person’s fault,” Mr. Sweeney said. Companies looking to reduce their exposure to litigation should look for ways to build good relationships with their consumers before potential problems arise. “That goodwill tends to reduce, more than anything, litigation,” Mr. Sweeney said. Mr. DeComo realizes having to defend against litigation is a possibility for many companies that make medical products for at-home use. “It’s one of those situations where we’re stuck between a rock and a hard place,” he said. “You’re trying to help patients, and you’re trying to make products as safe as possible, but anyone can come after a company.” (Source: Pittsburgh Business Times, April 14, 2003.)
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
临终关怀的新闻
随着越来越多的医疗保健产品(患者一次只能在医生的监督下通过医院使用)可供家庭使用,制造商、保险公司和医生面临着越来越大的潜在诉讼风险。病人现在能够自行实施曾经复杂的治疗,并操作医疗设备,如透析机或血液检测试剂盒。然而,与这些产品相关的便利性和降低医疗成本的同时,一些患者可能会错误地使用它们。如果发生人身伤害,可能很快就会发生诉讼。“对我们来说,承保这类风险相当具有挑战性,”新泽西州怀特豪斯车站Chubb & Son副总裁兼事故经理吉尔·沃德伦德(Jill Wadlund)说。据沃德伦德说,家用保健产品已经使用了几十年,但这一细分市场在过去三四年里出现了大幅增长。“它不会消失。如果有的话,它会变得更大。”Wadlund女士说,制造商在设计用于患者家庭的产品时需要考虑许多因素。安达与客户在测试和临床试验、FDA批准程序和产品引入阶段进行合作。“我们喜欢在它们还处于研发阶段的时候就开始着手,”瓦德伦德说。“他们在设计产品时需要向我们证明,他们了解产品的使用环境。在医院环境中,他们可以更细心一点。”肾透析产品生产商Renal Solutions Inc.的首席执行长德科莫(Pete DeComo)说,对于生产家用医疗产品的公司来说,保险可能是一个棘手的问题。由于保费通常基于产生的收入,因此售出的单位越多,潜在的责任风险就越大。“我认为,任何进入这种市场的公司都需要意识到,你的保费将会很高,”德科莫说。“当你使用被认为是高风险的设备时,这是一个挑战。”匹兹堡Eckert Seamans Cherin & Mellott律师事务所的产品责任律师汤姆•斯威尼(Tom Sweeney)曾与通用汽车(General Motors)等制造商合作。他警告说,无论制造商在产品开发上投入了多少精力,也不管产品附带了多少警告标签,一旦出现问题,仍有可能引发诉讼。“当你拥有这样一款产品,在消费者手中……你就有可能被起诉,即使是那个人的错,”斯威尼说。希望减少诉讼风险的公司应该在潜在问题出现之前,设法与消费者建立良好的关系。“这种善意往往更能减少诉讼,”斯威尼说。德科莫意识到,对于许多生产家用医疗产品的公司来说,不得不为诉讼辩护是一种可能。他说:“这是一种我们被困在岩石和硬地方之间的情况。”“你在努力帮助病人,你在努力让产品尽可能安全,但任何人都可以攻击一家公司。(资料来源:《匹兹堡商业时报》,2003年4月14日)
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Association Between Oral Health Status and Survival Time in Terminally Ill Cancer Patients Hospice news 2005 Cumulative subject index Hospice news Call for manuscripts
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1